AARTI DRUGS Financial Statement Analysis
|
||
|
The Revenues of AARTI DRUGS have increased by 7.47% YoY .
The Earnings Per Share (EPS) of AARTI DRUGS has increased by 15.96 % YoY. |
||
AARTI DRUGS Last 5 Annual Financial Results
[BOM: 524348|NSE : AARTIDRUGS]
| Consolidated | Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 |
|---|---|---|---|---|---|
| Revenues | ₹2,565 Cr | ₹2,387 Cr | ₹2,529 Cr | ₹2,716 Cr | ₹2,489 Cr |
| Expenses | ₹2,254 Cr | ₹2,097 Cr | ₹2,208 Cr | ₹2,407 Cr | ₹2,156 Cr |
| Operating Profit (Excl OI) | ₹312 Cr | ₹290 Cr | ₹321 Cr | ₹309 Cr | ₹333 Cr |
| Other Income | ₹2.39 Cr | ₹16 Cr | ₹4.03 Cr | ₹2.19 Cr | ₹11 Cr |
| Interest | ₹36 Cr | ₹39 Cr | ₹38 Cr | ₹37 Cr | ₹24 Cr |
| Depreciation | ₹67 Cr | ₹56 Cr | ₹51 Cr | ₹50 Cr | ₹50 Cr |
| Profit Before Tax | ₹211 Cr | ₹212 Cr | ₹236 Cr | ₹224 Cr | ₹270 Cr |
| Profit After Tax | ₹195 Cr | ₹168 Cr | ₹172 Cr | ₹166 Cr | ₹205 Cr |
| Consolidated Net Profit | ₹195 Cr | ₹168 Cr | ₹171 Cr | ₹166 Cr | ₹205 Cr |
| Earnings Per Share (Rs) | ₹21.36 | ₹18.42 | ₹18.65 | ₹17.96 | ₹22.14 |
| PAT Margin (%) | 7.60 | 7.04 | 6.79 | 6.12 | 8.24 |
| ROE(%) | 13.36 | 12.68 | 13.87 | 14.93 | 21.03 |
| ROCE(%) | 12.04 | 13.11 | 15.01 | 15.49 | 20.75 |
| Total Debt/Equity(x) | 0.37 | 0.45 | 0.44 | 0.51 | 0.52 |
Key Financials |
||
| Market Cap | : | ₹ 3,930.9 Cr |
| Revenue (TTM) | : | ₹ 2,677.6 Cr |
| Net Profit(TTM) | : | ₹ 191.1 Cr |
| EPS (TTM) | : | ₹ 20.9 |
| P/E (TTM) | : | 20.6 |
| Industry Peers & Returns | 1W | 1M | 1Y |
| AARTI DRUGS | -1.6% | 4.3% | -16.7% |
| SUN PHARMACEUTICAL INDUSTRIES | -1.8% | -7% | 14.3% |
| DIVIS LABORATORIES | -3.4% | 0.4% | 58.4% |
| TORRENT PHARMACEUTICALS | -2.7% | -3.6% | 36% |
| CIPLA | -3.9% | -4.7% | -10.1% |
| DR REDDYS LABORATORIES | 3% | 6.1% | -3.8% |
| MANKIND PHARMA | 1.2% | 4.4% | 0.6% |
| LUPIN | -2.7% | -6.2% | 3.5% |
| ZYDUS LIFESCIENCES | -1.4% | 0.1% | 15.5% |
AARTI DRUGS Revenues
[BOM: 524348|NSE : AARTIDRUGS]
| Y-o-Y | 7.47 % |
| 5 Yr CAGR | 0.76 % |
| Years | Revenues | % Change | |
|---|---|---|---|
| Mar2026 | ₹2,565 Cr | 7.47 | |
| Mar2025 | ₹2,387 Cr | -5.60 | |
| Mar2024 | ₹2,529 Cr | -6.90 | |
| Mar2023 | ₹2,716 Cr | 9.14 | |
| Mar2022 | ₹2,489 Cr | - | |
AARTI DRUGS Operating Profit
[BOM: 524348|NSE : AARTIDRUGS]
| Y-o-Y | 7.43 % |
| 5 Yr CAGR | -1.60 % |
| Years | Operating Profit | % Change | |
|---|---|---|---|
| Mar2026 | ₹312 Cr | 7.43 | |
| Mar2025 | ₹290 Cr | -9.54 | |
| Mar2024 | ₹321 Cr | 3.68 | |
| Mar2023 | ₹309 Cr | -6.96 | |
| Mar2022 | ₹333 Cr | - | |
| Operating Margins | |
|---|---|
| Y-o-Y | -0.08 % |
| 5 Yr CAGR | -2.35 % |
| Years | Operating Margin% | % Change | |
|---|---|---|---|
| Mar2026 | 12.15% | -0.08 | |
| Mar2025 | 12.16% | -4.18 | |
| Mar2024 | 12.69% | 11.41 | |
| Mar2023 | 11.39% | -14.75 | |
| Mar2022 | 13.36% | - | |
AARTI DRUGS Profit After Tax
[BOM: 524348|NSE : AARTIDRUGS]
| Y-o-Y | 15.91 % |
| 5 Yr CAGR | -1.26 % |
| Years | Profit After Tax | % Change | |
|---|---|---|---|
| Mar2026 | ₹195 Cr | 15.91 | |
| Mar2025 | ₹168 Cr | -1.90 | |
| Mar2024 | ₹171 Cr | 3.07 | |
| Mar2023 | ₹166 Cr | -18.89 | |
| Mar2022 | ₹205 Cr | - | |
| PAT Margins | |
|---|---|
| Y-o-Y | 7.95 % |
| 5 Yr CAGR | -2.00 % |
| Years | PAT Margin(%) | % Change | |
|---|---|---|---|
| Mar2026 | 7.6 % | 7.95 | |
| Mar2025 | 7.04 % | 3.68 | |
| Mar2024 | 6.79 % | 10.95 | |
| Mar2023 | 6.12 % | -25.73 | |
| Mar2022 | 8.24 % | - | |
AARTI DRUGS Earnings Per Share (EPS)
[BOM: 524348|NSE : AARTIDRUGS]
| Y-o-Y | 15.96 % |
| 5 Yr CAGR | -0.89 % |
| Years | EPS | % Change | |
|---|---|---|---|
| Mar2026 | ₹21 | 15.96 | |
| Mar2025 | ₹18 | -1.23 | |
| Mar2024 | ₹19 | 3.84 | |
| Mar2023 | ₹18 | -18.88 | |
| Mar2022 | ₹22 | - | |
AARTI DRUGS Return on Capital Employed (ROCE)
[BOM: 524348|NSE : AARTIDRUGS]
| Y-o-Y | -8.16 % |
| 5 Yr CAGR | -12.72 % |
| Years | ROCE | % Change | |
|---|---|---|---|
| Mar2026 | 12.04% | -8.16 | |
| Mar2025 | 13.11% | -12.66 | |
| Mar2024 | 15.01% | -3.10 | |
| Mar2023 | 15.49% | -25.35 | |
| Mar2022 | 20.75% | - | |
AARTI DRUGS Share Price vs Sensex
| Current Share Price | : | ₹430.6 |
| Current MarketCap | : | ₹ 3,930.9 Cr |
| Updated EOD on | : | Sep 30,2026 |
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| AARTI DRUGS | -1.6% |
4.3% |
-16.7% |
| SENSEX | -3.1% |
-6.2% |
-11.7% |
AARTI DRUGS related INDICES
| BSE Indices | 1W | 1M | 1Y |
|---|---|---|---|
| BSE 1000 | -3.5% | -5.7% | -4.7% |
| BSE HEALTHCARE | -4% | -3% | 12.3% |
| NSE Indices | 1W | 1M | 1Y |
|---|---|---|---|
| NIFTY MICROCAP 250 | -2% | -0.8% | 9.3% |
| NIFTY SMALLCAP 500 | -2.9% | -2.9% | NA |
| NIFTY TOTAL MARKET | -3.7% | -6% | -4.8% |
You may also like the below Video Courses
FAQ about AARTI DRUGS Financials
How the annual revenues of AARTI DRUGS have changed ?
The Revenues of AARTI DRUGS have increased by 7.47% YoY .
How the Earnings per Share (EPS) of AARTI DRUGS have changed?
The Earnings Per Share (EPS) of AARTI DRUGS has increased by 15.96 % YoY .
Check out Intrinsic Value of Peers of AARTI DRUGS
Compare Stock Analytics of Peers of AARTI DRUGS
SUN PHARMACEUTICAL INDUSTRIES LTD vs DIVIS LABORATORIES LTD vs TORRENT PHARMACEUTICALS LTD
CIPLA LTD vs DR REDDYS LABORATORIES LTD vs
SUN PHARMACEUTICAL INDUSTRIES LTD vs DIVIS LABORATORIES LTD vs TORRENT PHARMACEUTICALS LTD
CIPLA LTD vs DR REDDYS LABORATORIES LTD vs
